Raveglia; Luca Francesco
Patent Applications and Registrations
Patent applications and USPTO patent grants for Raveglia; Luca Francesco.The latest application filed is for "inhibitors of bruton's tyrosine kinase".
- Raveglia; Luca Francesco - Milan IT
- RAVEGLIA; Luca Francesco - Milano IT
- Raveglia; Luca Francesco - Baranzate di Bollate IT
- Raveglia; Luca Francesco - Bresso IT
| Patent | Date |
|---|---|
| Inhibitors of Bruton's tyrosine kinase Grant 9,580,416 - Chen , et al. February 28, 2 | 2017-02-28 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20160002225 - CHEN; Wei ; et al. | 2016-01-07 |
| 3-aminopyrrolidone derivatives Grant 8,063,039 - Thaler , et al. November 22, 2 | 2011-11-22 |
| 3-aminopyrrolidone derivatives Grant 7,968,592 - Thaler , et al. June 28, 2 | 2011-06-28 |
| 3-aminopyrrolidone Derivatives App 20100048665 - THALER; Florian ; et al. | 2010-02-25 |
| Quinoline derivatives Grant 7,482,458 - Farina , et al. January 27, 2 | 2009-01-27 |
| Quinoline-4-carboxamide As Nk-2 And Nk-3 Receptor Antagonists App 20070197546 - Giardina; Giuseppe Arnaldo Maria ; et al. | 2007-08-23 |
| 3-Aminopyrrolidone derivatives App 20070135410 - Thaler; Florian ; et al. | 2007-06-14 |
| Quinoline derivatives App 20060160846 - Farina; Carlo ; et al. | 2006-07-20 |
| Quinoline-4-carboxamide derivatives asNK-2 and NK-3 receptor antagonists App 20050159428 - Maria Giardina, Giuseppe Arnaldo ; et al. | 2005-07-21 |
| Quinoline derivatives(2) App 20050096316 - Farina, Carlo ; et al. | 2005-05-05 |
| Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists Grant 6,780,875 - Farina , et al. August 24, 2 | 2004-08-24 |
| Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists App 20040116469 - Giardina, Giuseppe Arnaldo Maria ; et al. | 2004-06-17 |
| Quinoline derivatives as NK3 antagonists Grant 6,743,804 - Giardina , et al. June 1, 2 | 2004-06-01 |
| Morphinoid compounds Grant 6,696,457 - Clarke , et al. February 24, 2 | 2004-02-24 |
| Quinoline derivatives(2) App 20030236281 - Farina, Carlo ; et al. | 2003-12-25 |
| Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists App 20030212101 - Farina, Carlo ; et al. | 2003-11-13 |
| Quinoline derivatives as NK3 antagonists App 20030195204 - Giardina, Giuseppe Arnaldo Maria ; et al. | 2003-10-16 |
| Quinoline derivatives as NK-2 and NK-3 receptor ligands Grant 6,613,770 - Farina , et al. September 2, 2 | 2003-09-02 |
| Quinoline derivatives(2) Grant 6,608,083 - Farina , et al. August 19, 2 | 2003-08-19 |
| Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists App 20030004183 - Giardina, Giuseppe Arnaldo Maria ; et al. | 2003-01-02 |
| Salts of quinoline derivatives as NK3 antagonists App 20020156097 - Maria-Giardina, Giuseppe Arnaldo ; et al. | 2002-10-24 |
| Salts Of Quinoline Derivatives As Nk3 Antagonists App 20020077335 - Giardina, Giuseppe Arnaldo ; et al. | 2002-06-20 |
| Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonists App 20020068827 - Giardina, Giuseppe Arnaldo Maria ; et al. | 2002-06-06 |
| Salts of quinoline derivatives as NK3 antagonists Grant 6,355,654 - Giardina , et al. March 12, 2 | 2002-03-12 |
| Quinoline derivatives Grant 6,277,862 - Giardina , et al. August 21, 2 | 2001-08-21 |
| Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists App 20010012846 - Glardina, Giuseppe Arnaldo Maria ; et al. | 2001-08-09 |
| Quinoline derivatives(2) Grant 5,811,553 - Farina , et al. September 22, 1 | 1998-09-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 